Amani A. L.
- Country
- France
- Department
- Centre René Huguenin
Research Overview
- Evaluation of Low-Dose Acetylsalicylic Acid for Chemoprevention of Colorectal Adenomas in Lynch Syndrome: A Randomized, Placebo-Controlled Trial
- Phase III Randomized Study of Adjuvant Chemotherapy with Levoleucovorin, Capecitabine, Folinic Acid, and Fluorouracil in Resected Stage III Colon Adenocarcinoma in Patients Aged 70+
Data & Insights
Has run more than one trial at 11 of 109 partner sites.
Specializations
Colorectal Oncology
The investigator specializes in treating high-risk stage III colon cancer, with particular emphasis on advancing adjuvant treatment approaches.
- Advanced Colon Cancer Management
- Post-surgical Treatment Strategies
- Disease-Free Survival Optimization
The investigator focuses on evaluating combination chemotherapy protocols incorporating irinotecan and oxaliplatin in the adjuvant setting.
Cancer Survivorship
Dedicated to improving long-term outcomes for patients through specialized focus on disease-free survival rates in colon cancer treatment.
- Survival Rate Assessment
- Treatment Effectiveness Monitoring
- Long-term Patient Outcomes
The investigator examines three-year survival metrics to evaluate therapeutic effectiveness in high-risk colorectal cases.
Adjuvant Therapy
Specializes in adjuvant treatment protocols for colon cancer patients who have undergone primary surgical intervention.
- Post-operative Care Protocols
- Risk-adapted Treatment Strategies
- Combination Therapy Approaches
The investigator develops therapeutic strategies for high-risk patients requiring intensive post-surgical treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.